Notice: This company has been marked as potentially delisted and may not be actively trading. Immuron (IMRN) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsHeadlinesShort InterestTrends Get the Latest News and Ratings for IMRN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Immuron and its competitors. Enter your email to sign up for newsletter Sign Up IMRN Analyst Ratings Over TimeTypeCurrent Forecast11/16/23 to 11/15/241 Month Ago10/17/23 to 10/16/243 Months Ago8/18/23 to 8/17/241 Year Ago11/16/22 to 11/16/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s) N/A N/A Buy1 Buy rating(s)1 Buy rating(s) N/A N/A Hold0 Hold rating(s)0 Hold rating(s) N/A N/A Sell0 Sell rating(s)0 Sell rating(s) N/A N/A Consensus Price Target$5.00$5.00N/AN/AForecasted Upside159.07% Upside150.00% UpsideN/AN/AConsensus RatingBuyBuyN/AN/A Trump Wins… But Elon Says Get Ready to Brace (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov IMRN Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History IMRN Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Immuron Stock vs. The CompetitionTypeImmuronMedical CompaniesS&P 500Consensus Rating Score 3.00 2.80 2.50Consensus RatingBuyModerate BuyModerate BuyPredicted Upside159.07% Upside26,221.88% Upside8.88% UpsideNews Sentiment RatingNeutral NewsSee Recent IMRN NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails9/26/2024Litchfield Hills Research1 of 5 starsS. YanchusSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.00+78.25%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:32 AM ET. IMRN Forecast - Frequently Asked Questions What is Immuron's forecast for 2025? According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Immuron is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. Should I buy or sell Immuron stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Immuron in the last twelve months. There is currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IMRN shares. Does Immuron's stock price have much upside? According to analysts, Immuron's stock has a predicted upside of 159.07% based on their 12-month stock forecasts. What analysts cover Immuron? Immuron has been rated by research analysts at Litchfield Hills Research in the past 90 days. Do Wall Street analysts like Immuron more than its competitors? Analysts like Immuron more than other "medical" companies. The consensus rating for Immuron is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how IMRN compares to other companies. Stock Forecasts and Research Tools Related Companies Verrica Pharmaceuticals Stock Forecast Carisma Therapeutics Stock Forecast DURECT Stock Forecast FibroGen Stock Forecast Fortress Biotech Stock Forecast Lantern Pharma Stock Forecast Daré Bioscience Stock Forecast CalciMedica Stock Forecast Lexaria Bioscience Stock Forecast Clene Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter 7 Cheap and Good Stocks (Ad)It's the holy grail of the stock market... Stocks that trade for pennies on the dollar yet have the potential to skyrocket for monster gains. Well, we've uncovered SEVEN such stocks.Simply follow this link and claim your copy today at no charge whatsoever. This page (NASDAQ:IMRN) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Immuron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMRN Stock Alerts